Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 198-204

  Desforges Bullet, Virginie ^a   Gallo, Cécile ^a   Lefebvre, Catherine ^a   Pigny, Pascal ^b   Dewailly, Didier ^a   Catteau Jonard, Sophie ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Anti M llerian hormone; follicular fluid; FSH; M llerian inhibiting substance; polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FRANCE; GRANULOSA CELL; HORMONE SYNTHESIS; HUMAN; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE; PRIORITY JOURNAL; PUNCTURE; UNIVERSITY HOSPITAL;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; GRANULOSA CELLS; HUMANS; OOCYTES; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 77951578326     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.03.004     Document Type: Article

References (32)

1. Weenen C., Laven J.S., Von Bergh A.R., Cranfield M., Groome N.P., Visser J.A., et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10 (2004) 77-83
2. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Ingraham H.A., Nachtigal M.W., et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143 (2002) 1076-1084
3. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Kumar T.R., Matzuk M.M., et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142 (2001) 4891-4899
4. Norman R.J., Dewailly D., Legro R.S., and Hickey T.E. Polycystic ovary syndrome. Lancet 370 (2007) 685-697
5. Jonard S., and Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10 (2004) 107-117
6. Hughesdon P.E. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv 37 (1982) 59-77
7. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88 (2003) 5957-5962
8. Laven J.S., Mulders A.G., Visser J.A., Themmen A.P., De Jong F.H., and Fauser B.C. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89 (2004) 318-323
9. Das M., Gillott D.J., Saridogan E., and Djahanbakhch O. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 23 (2008) 2122-2126
10. Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92 (2007) 240-245
11. Fallat M.E., Siow Y., Marra M., Cook C., and Carrillo A. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 67 (1997) 962-965
12. Dumesic D.A., Lesnick T.G., Booher J., Wong A., Ball G.D., and Abbott D.H. Intrafollicular anti-Müllerian hormone (AMH) levels positively correlate with follicle sensitivity to follicle stimulating hormone (FSH) and are elevated in polycystic ovary syndrome (PCOS). Fertil Steril 88 Suppl 1 (2007) S6-S7
13. Catteau-Jonard S., Jamin S.P., Leclerc A., Gonzales J., Dewailly D., and di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93 (2008) 4456-4461
14. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., et al. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136 (1995) 4951-4962
15. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
16. Catteau-Jonard S., Pigny P., Reyss A.C., Decanter C., Poncelet E., and Dewailly D. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J Clin Endocrinol Metab 92 (2007) 4138-4143
17. Andersen C.Y., and Lossl K. Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B. Fertil Steril 89 (2008) 1760-1765
18. Pigny P., Jonard S., Robert Y., and Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 941-945
19. Eldar-Geva T., Margalioth E.J., Gal M., Ben-Chetrit A., Algur N., Zylber-Haran E., et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 20 (2005) 1814-1819
20. Yding Andersen C., Rosendahl M., and Byskov A.G. Concentration of anti-Mullerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles. J Clin Endocrinol Metab 93 (2008) 2344-2349
21. Dumesic D.A., Lesnick T.G., Stassart J.P., Ball G.D., Wong A., and Abbott D.H. Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril (2008) in press
22. Foong S.C., Abbott D.H., Zschunke M.A., Lesnick T.G., Phy J.L., and Dumesic D.A. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab 91 (2006) 2327-2333
23. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., and Shelden R.M. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
24. van Rooij I.A., Broekmans F.J., te Velde E.R., Fauser B.C., Bancsi L.F., de Jong F.H., et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
25. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
26. Erickson G.F., Magoffin D.A., Garzo V.G., Cheung A.P., and Chang R.J. Granulosa cells of polycystic ovaries: are they normal or abnormal?. Hum Reprod 7 (1992) 293-299
27. Mason H.D., Willis D.S., Beard R.W., Winston R.M., Margara R., and Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 79 (1994) 1355-1360
28. Almahbobi G., Anderiesz C., Hutchinson P., McFarlane J.R., Wood C., and Trounson A.O. Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol (Oxf) 44 (1996) 571-580
29. Voss A.K., and Fortune J.E. Levels of messenger ribonucleic acid for cholesterol side-chain cleavage cytochrome P-450 and 3 beta-hydroxysteroid dehydrogenase in bovine preovulatory follicles decrease after the luteinizing hormone surge. Endocrinology 132 (1993) 888-894
30. Cupisti S., Dittrich R., Mueller A., Strick R., Stiegler E., Binder H., et al. Correlations between anti-mullerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. Eur J Med Res 12 (2007) 604-608
31. Fanchin R., Mendez Lozano D.H., Frydman N., Gougeon A., di Clemente N., Frydman R., et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 92 (2007) 1796-1802
32. Takahashi C., Fujito A., Kazuka M., Sugiyama R., Ito H., and Isaka K. Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril 89 (2008) 586-591